Gene · 3980
Papers1,941
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 1,941
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Combining PARP Inhibition with Platinum, Ruthenium or Gold Complexes for Cancer Therapy. | ChemMedChem | 2020 | 32812709 | PubTator, text mining | PubMed |
| UFMylation maintains tumour suppressor p53 stability by antagonizing its ubiquitination. | Nat Cell Biol | 2020 | 32807901 | PubTator, text mining | PubMed |
| PARP Inhibitors in Endometrial Cancer: Current Status and Perspectives. | Cancer Manag Res | 2020 | 32801862 | PubTator, text mining | PubMed |
| The Chromatin Response to Double-Strand DNA Breaks and Their Repair. | Cells | 2020 | 32784607 | PubTator, text mining | PubMed |
| PARP inhibition and immune modulation: scientific rationale and perspectives for the treatment of gynecologic cancers. | Ther Adv Med Oncol | 2020 | 32782491 | PubTator, text mining | PubMed |
| Correlation between the genetic variants of base excision repair (BER) pathway genes and neuroblastoma susceptibility in eastern Chinese children. | Cancer Commun (Lond) | 2020 | 32780923 | PubTator, text mining | PubMed |
| ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents. | JCI Insight | 2020 | 32780723 | PubTator, text mining | PubMed |
| XRCC1 promotes replication restart, nascent fork degradation and mutagenic DNA repair in BRCA2-deficient cells. | NAR Cancer | 2020 | 32776008 | PubTator, text mining | PubMed |
| Acrylamide exposure represses neuronal differentiation, induces cell apoptosis and promotes tau hyperphosphorylation in hESC-derived 3D cerebral organoids. | Food Chem Toxicol | 2020 | 32763439 | PubTator, text mining | PubMed |
| Mitochondrial Dysfunction, Neurogenesis, and Epigenetics: Putative Implications for Amyotrophic Lateral Sclerosis Neurodegeneration and Treatment. | Front Neurosci | 2020 | 32760239 | PubTator, text mining | PubMed |
| Molecular Transducers of Human Skeletal Muscle Remodeling under Different Loading States. | Cell Rep | 2020 | 32755574 | PubTator, text mining | PubMed |
| Expanding molecular roles of UV-DDB: Shining light on genome stability and cancer. | DNA Repair (Amst) | 2020 | 32739133 | PubTator, text mining | PubMed |
| PARP Inhibitor Resistance Mechanisms and Implications for Post-Progression Combination Therapies. | Cancers (Basel) | 2020 | 32722408 | PubTator, text mining | PubMed |
| Evaluation of the Efficacy and Safety of PARP Inhibitors in Advanced-Stage Epithelial Ovarian Cancer. | Front Oncol | 2020 | 32719741 | PubTator, text mining | PubMed |
| Activation of DNA-PK by hairpinned DNA ends reveals a stepwise mechanism of kinase activation. | Nucleic Acids Res | 2020 | 32716029 | PubTator, text mining | PubMed |
| Influence of Two DNA Repair Pathway Polymorphisms in Colorectal Cancer Risk in Southwest Iran. | Asian Pac J Cancer Prev | 2020 | 32711416 | PubTator, text mining | PubMed |
| Characterisation of Ovarian Cancer Cell Line NIH-OVCAR3 and Implications of Genomic, Transcriptomic, Proteomic and Functional DNA Damage Response Biomarkers for Therapeutic Targeting. | Cancers (Basel) | 2020 | 32709004 | PubTator, text mining | PubMed |
| Minireview Exploring the Biological Cycle of Vitamin B3 and Its Influence on Oxidative Stress: Further Molecular and Clinical Aspects. | Molecules | 2020 | 32707945 | PubTator, text mining | PubMed |
| Cross-species oncogenic signatures of breast cancer in canine mammary tumors. | Nat Commun | 2020 | 32680987 | PubTator, text mining | PubMed |
| DNA Damage: From Threat to Treatment. | Cells | 2020 | 32664329 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3980/papers?page=35